KLA gains as more complex AI chips require more inspection before they ship. 3D stacking, advanced packaging and 2nm processes multiply checks in a market KLA says it owns almost entirely. Revenue rose 29% and EPS 39%; the next-quarter revenue guide of $4.7bn exceeds the $4.54bn expected, showing the promised second-half acceleration. Overweight, $300 target. x.com  x.com 

KLA looks cheap against its earnings: at 30x next year's earnings versus the roughly 38x chip-equipment makers usually get, it sits about 9% below the low end of a $224–$285 fair range. That range is 38x next year's $6.71 EPS, give or take 12%, and leans on the forecast, which is 83% above trailing earnings; on trailing earnings it trades at 56x. This is a valuation read only, with no fundamental work. x.com 

KLA and its chip-equipment peers are best bought at significantly lower valuations during a down cycle, so downside risk ahead matters more than near-term upside. KLA is only being built up slowly to fix an underweight versus Applied Materials, ASML, Lam Research and Tokyo Electron, with more added if it falls further, and no concern if it jumps back to $250 in the meantime. x.com 

KLA's first stock split in 26 years, a 10-for-1, signals what management expects for 2027 demand. Past 2-for-1 and 3-for-1 splits have lifted the shares 5-10%, and this split is five times larger. x.com 

KLA is a structural near-monopoly in semiconductor process control, not a cyclical equipment vendor, with about 56% of process control and over 85% of optical wafer inspection. It combines pricing power, rising process-control content per wafer as chips grow more complex, and a recurring services base whose lifetime revenue per tool exceeds the tool's original price. Whichever AI application wins, chipmakers must pay the KLA toll as long as they demand smaller, faster chips. x.com  x.com 

KLA has almost no upside even in a best case. Beating 2027 Street EPS estimates of $5 by 100% and applying a 30x multiple, a material premium to its history for the growth, leaves only 1.5% upside. x.com 

ACM Research carries binary China risk: China is about 97% of its business, and authorities could stop it any day, forcing management to choose between San Jose and China. The CCP's threats toward other countries make that exposure uglier, whatever the company's $4B revenue ambition. x.com  x.com  x.com 

AXT's bull case hinges on supply rather than demand, and China holds many of the cards. Demand is growing strongly, but China can reasonably be expected to favor its own industry and permit exports only where they serve its broader interests, which argues against overly optimistic forecasts. @larmatrade notes over half of revenue is now domestic Chinese; if half of demand is Chinese, AXT should to some extent be valued like a Chinese company, and the market is likely to price it so over time. … Show more

KLA trades at a premium valuation despite lower growth and less specialization in advanced packaging, the hottest AI segment. Camtek and Onto Innovation often win specific inspection and metrology sockets with better throughput, cost of ownership and packaging-optimized 2D/3D performance, while KLA, dominant overall, is sometimes less specialized for the hardest HBM and hybrid bonding steps. Onto shows the strongest Rule of X at the lowest cash-flow multiple. x.com 

Nvidia looks undervalued even on its US business alone, since it is reaching new highs without any China sales. x.com  x.com